Effect of polymorphism on in vitro-in vivo properties of carbamazepine conventional tablets

Journal of Drug Delivery Science and Technology

Volumn 14, Issue 2, 2004, Pages 147-153

  Elqidra, R ^a   Unlu N ^b   Capan Y ^b   Sahin, G ^b   Dalkara, T ^b   Hincal, A A ^b  

^a AL AZHAR UNIVERSITY   (Palestine)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bioavailability; Carbamazepine; In vitro dissolution; Polymorphism

Indexed keywords

ACETONITRILE; CARBAMAZEPINE; WATER;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NORMAL HUMAN; OPEN STUDY; POWDER; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; TABLET PROPERTY;

EID: 1942441440     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(04)50027-8     Document Type: Article

References (25)

1. UMEDA T., OHNISHI N., YOKOYAMA T., KURODA K., KURODA T., TATSUMI E., MATSUDA Y. - Kinetic of thermal transformation of carbamazepine polymorphic forms in solid-state. - Yakugaku Zasshi, 104, 786-792, 1984.
2. KRAHN F.U., MIELCK J.B. - Relations between several polymorphic forms and the dihydrate of carbamazepine. - Pharm. Acta Helv., 62, 247-254, 1987.
3. LEFEBVRE C., GUYOT-HERMANN A.M., DRAGUET-BRUGHMANS M., BOUCHE R., GUYOT J.C. - Polymorphic transitions of carbamazepine during grinding and compression. - Drug. Dev. Ind. Pharm., 12, 1913-1927, 1986.
4. YOUNG W.W.L., SURYANARAYANAN R. - Kinetics of transition of anhydrous carbamazepine to carbamazepine dihydrate in aqueous suspensions. - J. Pharm. Sci., 80, 496-500, 1991.
5. LAINE E., TUOMINEN V., ILVESSALO P., KAHELA P. - Formation of dihydrate from carbamazepine anhydrate in aqueous conditions. - Int. J. Pharm., 20, 307-314, 1984.
6. KANENIWA N., YAMAGUCHI T., WATARI N., OTSUKA M. - Hygroscopicity of carbamazepine crystalline powders. - Yakugaku Zasshi, 104, 184-190, 1984.
7. WANG J.T., SHIU G.K., WORSTAY W., VISWANATHAN C.T., SKELLY J.P. - Effect of humidity and temperature on in vitro performance of carbamazepine tablets. - Pharm. Res., 9 (Suppl.), S143, 1990.
8. OTSUKA M., HASEGAWA H., MATSUDA Y. - Effect of polymorphic forms of bulk powders on pharmaceutical properties of carbamazepine granules. - Chem. Pharm. Bull., 47, 852-856, 1999.
9. RIVA R., ALBANI F., AMBROSETTO G., CONTIN M., CORTELLI P., PERUCCA E., BARUZZI A. - Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects. - Epilepsia, 25, 476-481, 1984.
10. LEVY R.H., PITLICK W.H., TROUPIN A.S., GREEN J.R. NEAL J.M. - Pharmacokinetics of carbamazepine in normal man. - Clin. Pharmacol. Therap., 17, 657-668, 1975.
11. KAHELA P., AALTONEN R., LEWING E., ANTTILA M., KRISTOFFERSSON E. - Pharmacokinetics and dissolution of two crystalline forms of carbamazepine. - Int. J. Pharm., 14, 103-112, 1983.
12. KOBAYASHI Y., ITO S., ITAI S., YAMAMOTO K. - Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. - Int. J. Pharm., 193, 137-146, 2000.
13. BELL W.L., CRAWFORD I.L., SHIU G.K. - Reduced bioavailability of moisture-exposed carbamazepine resulting in status epilepticus. - Epilepsia, 34, 1102-1104, 1993.
14. KRAHN F.U., MIELCK J.B. - Effect of type and extent of crystalline order on chemical and physical statability of carbamazepine. - Int. J. Pharm., 53, 25-34, 1989.
15. MACKICHAN J.J. - Simultaneous liquid chromatographic analysis for carbamazepine and carbamazepine 10-11, epoxide in plasma and saliva by use of double internal standardization. - J. Chromat., 181, 337-383, 1980.
16. LOWES M.M.J., CAIRA M.R., LÖTTER A.P. VAN DER WATT J.G. - Physicochemical properties and x-ray structural studies of the trigonal polymorph of carbamazepine. - J. Pharm. Sci., 76, 744-752, 1987.
17. GOSSELIN RM., THIBERT R., PREDA M., MCMULLEN J.N. - Polymorphic properties of micronized carbamazepine produced by RESS. - Int. J. Pharm., 252, 225-233, 2003.
18. ROBERTS R.J., PAYNE R.S., ROWE R.C. - Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. - Eur. J. Pharm. Sci., 9, 277-283, 2000.
19. KALA H., HAACK U., POLLANDT P., BREZESINSKI G. - Zur polymorhpie des carbamazepins. - Acta Pharm. Technol., 32, 72-77, 1986.
20. BEHME R.J., BROOKE D. - Heat of fussion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. - J. Pharm. Sci, 80, 986-990, 1991.
21. McMAHON L.E., TIMMINS P., WILLIAMS A.C., YORK P. - Characterization of dihydrates prepared from carbamazepine polymorphs. - J. Pharm. Sci., 85, 1064-1069, 1996.
22. MATSUDA T., AKAZAWA R., TERAOKA R., OTSUKA M. - Pharmaceutical evaluation of carbamazepine modifications: Comparative study for photostability of carbamazepine polymorphs by using fourrier-transformed reflection-absorption infrared spectroscopy and colorimetric measurement. - J. Pharm. Pharmacol., 46, 162-167, 1994.
23. DAM M., CHRISTIANSEN J., KRISTENSEN C.B., HELLES A., JAEGERSKOU A., SCHMIEGELOW M. - Carbamazepine: a clinical biopharmaceutical study. - Eur. J. Clin. Pharnmacol., 20, 59-64, 1981.
24. MEYER M.C., STRAUGHIN A.B., MHATRE R.M., SHAH V.P., WILLIAMS R.L., LESKO L.J. - The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets. - Pharm. Res., 15, 1787-1791, 1998.
25. RIAD L.E., CHAN K.K.H., WAGNER JR W.E., SAWCHUK R.J. - Simultaneous first-and zero-order absorption of carbamazepine tablets in human. - J. Pharm. Sci., 75, 897-900, 1986.